Phorbol ester decreases cytosolic retinoic acid binding protein (CRABP) capacity in normal but not psoriatic epidermis.
Junquero
D
D
Basset-Seguin
N
N
Modat
G
G
Levy
C
C
Guilhou
J J
JJ
Bonne
C
C
D000255:Adenosine Triphosphate / Q000494:pharmacology; D001667:Binding, Competitive / Q000187:drug effects; D002352:Carrier Proteins / Q000378:metabolism*; D003600:Cytosol / Q000378:metabolism; D004817:Epidermis / Q000378:metabolism*; D006801:Humans; D010703:Phorbol Esters / Q000494:pharmacology*; D011485:Protein Binding / Q000187:drug effects; D011565:Psoriasis / Q000378:metabolism*; D018168:Receptors, Retinoic Acid; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D014212:Tretinoin / Q000378:metabolism
D002352:Carrier Proteins; D010703:Phorbol Esters; D018168:Receptors, Retinoic Acid; D014212:Tretinoin; D000255:Adenosine Triphosphate; D013755:Tetradecanoylphorbol Acetate